Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...
In Terms of performance its possible that the new bike might possibly be powered by a 398 cc liquid cooled engine - Details ...
High hopes, high hopes, Paul Walter Hauser is giving us high hopes. The Fantastic Four: First Steps is on the horizon, and ...
In downstream processing of biopharmaceutical products, protein aggregation presents one of the main risks in terms of ...
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time gene therapy for the treatment of patients with vision loss due to a ...
Penny Goldstone is the Contributing Fashion Editor at Marie Claire UK. She writes about catwalk trends and the latest high street and Instagram sartorial must-haves. She also helms the Women Who Win ...
Harvard physicists develop a novel cascaded-mode interferometer, enhancing light control for applications in fiber-optic ...